Press Announcements
Note: Press announcements from 2004 to 2012 are available through the FDA Archive. Some links in press announcements may no longer be active. For more information, contact FDA’s Office of Media Affairs at 301-796-4540.
May 2016
- May 20, 2016 - FDA modernizes Nutrition Facts label for packaged foods
- May 18, 2016 - FDA approves new, targeted treatment for bladder cancer
- May 10, 2016 - FDA issues rule for data collection of antimicrobial sales and distribution by animal species
- May 05, 2016 - FDA reminds health care professionals not to use drug products intended to be sterile from Medaus
- May 05, 2016 - FDA takes significant steps to protect Americans from dangers of tobacco through new regulation
- May 03, 2016 - Federal court orders rice noodle company to stop selling products until it complies with food safety regulations
- May 02, 2016 - FDA launches public education campaign to prevent and reduce tobacco use among LGBT young adults
April 2016
- April 29, 2016 - Federal judge enters order of permanent injunction against Paul W. Franck
- April 29, 2016 - FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease
- April 29, 2016 - FDA approves first generic Crestor
- April 22, 2016 - FDA proposes ban on electrical stimulation devices intended to treat self-injurious or aggressive behavior
- April 19, 2016 - FDA launches first ad campaign focused on dangers of smokeless tobacco among rural teens
- April 14, 2016 - FDA approves folic acid fortification of corn masa flour
- April 11, 2016 - FDA approves new drug for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality
- April 08, 2016 - FDA takes steps to withdraw approval of the swine drug carbadox due to safety concerns
- April 07, 2016 - FDA allows marketing of first-of-kind tissue containment system for use with certain laparoscopic power morcellators in select patients
- April 06, 2016 - FDA approves first leadless pacemaker to treat heart rhythm disorders
- April 05, 2016 - FDA approves Inflectra, a biosimilar to Remicade
- April 05, 2016 - FDA releases final rule to ensure food safety during transport
- April 01, 2016 - FDA proposes limit for inorganic arsenic in infant rice cereal
March 2016
- March 30, 2016 - FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow
- March 30, 2016 - FDA allows use of investigational test to screen blood donations for Zika virus
- March 24, 2016 - FDA takes important step to increase the development of, and access to, abuse-deterrent opioids
- March 23, 2016 - FDA approves Cinqair to treat severe asthma
- March 22, 2016 - FDA approves new psoriasis drug Taltz
- March 22, 2016 - FDA announces enhanced warnings for immediate-release opioid pain medications related to risks of misuse, abuse, addiction, overdose and death
- March 21, 2016 - FDA proposes ban on most powdered medical gloves
- March 21, 2016 - FDA approves new treatment for inhalation anthrax
- March 11, 2016 - FDA expands use of Xalkori to treat rare form of advanced non-small cell lung cancer
- March 04, 2016 - FDA permits marketing of device that senses optimal time to check patient’s eye pressure
- March 04, 2016 - FDA approves first coagulation factor-albumin fusion protein to treat patients with hemophilia B
- March 03, 2016 - FDA and DOJ take action against Virginia soybean business for selling contaminated sprouts
- March 01, 2016 - FDA issues recommendations to reduce the risk of Zika virus transmission by human cell and tissue products
February 2016
- February 29, 2016 - FDA takes additional action to better understand safety of Essure, inform patients of potential risks
- February 29, 2016 - FDA providing $2 million in new grants for natural history studies in rare diseases
- February 26, 2016 - Federal judge approves consent decree with Florida dietary supplement distributor, Viruxo
- February 24, 2016 - FDA Statement on Senate Confirmation of Dr. Robert M. Califf
- February 19, 2016 - FDA approves Briviact to treat partial onset seizures
- February 16, 2016 - FDA issues recommendations to reduce the risk for Zika virus blood transmission in the United States
- February 16, 2016 - Maine smoked fish company agrees to halt production of adulterated fish
- February 09, 2016 - FDA seeks $5.1 billion total for FY 2017, including funds to implement food safety law, improve medical product safety and quality
- February 04, 2016 - Califf, FDA top officials call for sweeping review of agency opioids policies
January 2016
- January 28, 2016 - FDA approves Zepatier for treatment of chronic hepatitis C genotypes 1 and 4
- January 28, 2016 - FDA approves first drug to show survival benefit in liposarcoma
- January 22, 2016 - FDA resolves criminal and civil actions against cheese manufacturer
- January 15, 2016 - FDA outlines cybersecurity recommendations for medical device manufacturers
- January 15, 2016 - FDA clears Olympus TJF-Q180V duodenoscope with design modifications intended to reduce infection risk
- January 11, 2016 - Federal judge enters consent decree against Downing Labs
- January 07, 2016 - FDA approves Integra Omnigraft Dermal Regeneration Matrix to treat diabetic foot ulcers
- January 06, 2016 - US Marshals seize dietary supplements containing kratom